dc.contributor.author
Schneider, Taiane
dc.contributor.author
Martinez-Martinez, Arturo
dc.contributor.author
Cubillos Rojas, Mónica
dc.contributor.author
Bartrons Bach, Ramon
dc.contributor.author
Ventura Pujol, Francesc
dc.contributor.author
Rosa López, José Luis
dc.date.issued
2020-11-18T07:58:55Z
dc.date.issued
2020-11-18T07:58:55Z
dc.date.issued
2019-06-18
dc.date.issued
2020-11-18T07:58:56Z
dc.identifier
https://hdl.handle.net/2445/172166
dc.description.abstract
Ubiquitin ligases regulate numerous cellular processes, including tissue homeostasis, cellular metabolism, and cell cycle progression. These enzymes recognize, interact with and ubiquitylate specific substrates. Homologous to the E6-AP carboxyl terminus (HECT) and regulator of chromosome condensation 1 (RCC1)-like domain-containing proteins (HERCs) belong to the family of HECT ubiquitin ligases. There are six human HERCs which can be divided into two subgroups: large HERCs (HERC1-2) and small HERCs (HERC3-6). Alterations in the function of large HERCs are associated with serious pathologies such as neurological disorders. Mutations in human HERC1 have been associated with overgrowth, intellectual disability and some autistic features; while mutations in HERC2 have been identified as the cause of a neurodevelopmental disorder with similarities to Angelman syndrome and autism.
dc.format
application/pdf
dc.publisher
Frontiers Media
dc.relation
Reproducció del document publicat a: https://doi.org/10.3389/fonc.2019.00524
dc.relation
Frontiers In Oncology, 2019, vol. 9, p. 524
dc.relation
https://doi.org/10.3389/fonc.2019.00524
dc.rights
cc-by (c) Schneider, Taiane et al., 2019
dc.rights
http://creativecommons.org/licenses/by/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Ciències Fisiològiques)
dc.subject
Proteïnes supressores de tumors
dc.subject
Tumor suppressor protein
dc.title
Large HERCs function as tumor suppressors
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion